Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy
Year: 2008
Type: article
Source: Toxicology
Institutions: Copenhagen University Hospital, University of Manitoba
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Israel Cancer Research Fund
OpenAlex ID: W1997306293
